IL17A and Chagas disease: A follow-up study in school-aged children with Chagas disease found that higher IL-17A levels were associated with the persistence of infection after treatment with benznidazole, suggesting this cytokine could be a possible biomarker for nonresponse to treatment and the persistence of infection [54].